Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

Twenty Brazilian Cannabis Patient Associations Are Meeting Inside a Free Arts Fair in Fortaleza

Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…

2 hours ago

In 1968 I Faced 70 Years for Giving Away Joints. Fifty-Five Years Later, I Paid $32.16 at the Counter.

In 1968, a few joints I gave away left me facing the possibility of decades…

2 hours ago

A $31.8 Million Reminder That Cannabis Contracts Are Worthless Because Weed is Not Legal Under Federal Law

Here's the part that should worry every operator, investor, and vendor in the industry: this…

2 hours ago

The Cold Stops the Clock: How Fresh Frozen Cannabis Becomes Live Rosin

For one hash maker the clock starts at harvest, and the flower is in the…

2 days ago

Greening Out: Why a Cannabis-Induced Psychedelic State is No Joke

Cannabis can absolutely take you somewhere that looks like a classic psychedelic experience. It just…

2 days ago

Prehistoric High: 25,000-Year-Old Teeth May Hold the Oldest Evidence of Psychoactive Drug Use

Researchers analyzing two ancient skeletons from Indonesia found dramatic dental wear and traces of arecoline,…

3 days ago